Glen Eagle Advisors’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-78
Closed -$1.02K 1060
2023
Q3
$1.02K Hold
78
﹤0.01% 935
2023
Q2
$983 Hold
78
﹤0.01% 959
2023
Q1
$1.02K Hold
78
﹤0.01% 955
2022
Q4
$1.38K Hold
78
﹤0.01% 965
2022
Q3
$1.19K Hold
78
﹤0.01% 949
2022
Q2
$1.16K Hold
78
﹤0.01% 889
2022
Q1
$1.76K Hold
78
﹤0.01% 820
2021
Q4
$1.44K Hold
78
﹤0.01% 840
2021
Q3
$1.04K Hold
78
﹤0.01% 985
2021
Q2
$1.44K Buy
+78
New +$1.31K ﹤0.01% 955

Other funds holding MDRX

Glen Eagle Advisors's MDRX Position: Q4 2023 in Review

Glen Eagle Advisors sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2023, closing a stake of 78 shares — an estimated $1.02K sold.

Glen Eagle Advisors first reported a position in MDRX in Q2 2021 and held it in 10 quarters. The position peaked at $1.76K in Q1 2022. 225 funds tracked by Wall St. Rank hold MDRX as of Q4 2023.

  • Glen Eagle Advisors reported no remaining Veradigm Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Glen Eagle Advisors sold 78 Veradigm Inc. Common Stock shares in Q4 2023, an estimated $1.02K.
  • Glen Eagle Advisors first reported a position in Veradigm Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Glen Eagle Advisors's Veradigm Inc. Common Stock position peaked at $1.76K in Q1 2022.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2023.

Based on Glen Eagle Advisors's 13F filing for Q4 2023, filed 13 Aug 2024.